Atara Biotherapeutics, Inc.ATRANASDAQ

Revenue (LTM)

$121M

-6.3% YoY

Net Income (LTM)

$33M

+138.3% YoY

Free Cash Flow

$-51M

Revenue CAGR (5Y)

+56.1%

Marginsimproving

FCF($0.1B)

Now profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	20	64↑212.6%	9↓86.5%	129↑1404.0%	121↓6.3%
Gross Profit	-262	64↑124.3%	-0↓100.5%	108↑34582.7%	100↓7.8%
Operating Income	-340	-281↑17.6%	-276↑1.6%	-83↑69.8%	36↑143.0%
Net Income	-340	-228↑32.9%	-276↓20.9%	-85↑69.1%	33↑138.3%
EBITDA	-331	-222↑32.9%	-266↓19.7%	-76↑71.5%	50↑166.5%
EPS Diluted	-90.78	-55.96↑38.4%	-65.18↓16.5%	-11.41↑82.5%	2.57↑122.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	106	93↓12.4%	26↓72.2%	25↓3.1%	8↓66.1%
Total Current Assets	385	295↓23.3%	102↓65.5%	65↓36.3%	12↓81.2%
Total Assets	468	376↓19.6%	166↓56.0%	109↓34.1%	20↓81.5%
Total Current Liabilities	106	79↓25.4%	142↑80.2%	135↓5.4%	15↓88.9%
Total Liabilities	189	250↑32.5%	265↑6.0%	206↓22.0%	59↓71.5%
Total Equity	280	127↓54.7%	-99↓178.4%	-97↑2.0%	-39↑60.4%
Total Debt	28	72↑153.6%	58↓19.3%	44↓24.3%	53↑20.5%
Net Debt	-78	-21↑72.7%	32↑250.8%	19↓41.3%	44↑135.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-221	-270↓22.6%	-193↑28.6%	-69↑64.4%	-51↑25.9%
Capital Expenditure	-11	-4↑60.4%	-1↑70.8%	-0↑79.9%	0
Free Cash Flow	-231	-275↓18.8%	-194↑29.3%	-69↑64.5%	-51↑26.1%
Stock-Based Comp	54	54↓0.1%	45↓15.7%	27↓40.5%	10↓63.9%
Net Change in Cash	-94	-14↑84.7%	-67↓366.3%	-1↑98.8%	-17↓1958.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance